ARDELYX

Lobbying client · Massachusetts · filed 2025 to 2026

BioPharma Company

$320,000 Reported spend

7 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page is grouped by the client's LDA id (64924), not by name.

Firms hired 1

THE MCMANUS GROUP $320,000 7 filings

Bills named in these filings 1

HR 6214
Kidney Care Access Protection Act

2 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $200,000 5 filings

Issues lobbied 2

Medicare/Medicaid 6
Health Issues 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 6
SENATE 6
Office of Management & Budget (OMB) 2
Health & Human Services, Dept of (HHS) 1

Recent filings 7 total

Q2

THE MCMANUS GROUP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026

View → Q1

THE MCMANUS GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 20, 2026

View → Q4

THE MCMANUS GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 20, 2026

View → Q3

THE MCMANUS GROUP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 20, 2025

View → Q2

THE MCMANUS GROUP

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Aug 4, 2025

View → Q1

THE MCMANUS GROUP

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $20,000 income · posted Apr 21, 2025

View → RR

THE MCMANUS GROUP

1st Quarter (Jan 1 - Mar 31) 2025 · posted Mar 17, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.